Neuroendocrine tumours trials in Sweden
5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Gothenburg, Lund, Stockholm, Uppsala
- Age
- 12 years and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - Phase 3Taking peopleDAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
- Where
- Goteborg, Lund, Uppsala
- Age
- 18 years and over
- People
- 390 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07544654 · EU 2025-523869-22-00 - No phaseTaking peopleMulticenter Study for External Validation of the TB-NET Score
- Where
- Uppsala
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
See details and how to joinNCT07903532 - No phaseTaking peoplePancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not
- Where
- Gothenburg, Lund, Stockholm, Uppsala
- Age
- 18 years and over
- People
- 200
- Run by
- Uppsala University
See details and how to joinNCT07273409 - Phase 3Taking peopleSystemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.
- Where
- Gothenburg, Lund, Stockholm, Uppsala
- Age
- 18 years and over
- People
- 300
- Run by
- Lund University Hospital
See details and how to joinNCT05387603